Skip to main content
. 2013 Aug 27;8(8):e72399. doi: 10.1371/journal.pone.0072399

Figure 1. Description of the patient subgroups.

Figure 1

ITM, idiopathic transverse myelitis; OIND, other inflammatory neurological diseases; NS, neurosarcoidosis; PNS, paraneoplastic syndrome; NL, neurolupus; NB, neuro-Behcet’s disease; PACNS, primary angiitis of the central nervous system; NBo, neuroborreliosis; NSj, neuro-Sjögren’s syndrome; CSS, Churg-Strauss syndrome; WG, Wegener granulomatosis; DD, demyelinating diseases; ON, optic neuritis; CIS, clinically isolated syndrome; RRMS, relapsing-remitting multiple sclerosis; PPMS, primary progressive multiple sclerosis; NIND, non-inflammatory neurological diseases; PNP, peripheral polyneuropathy; PH, primary headaches; LD, lumbar discopathy; NPH, normal pressure hydrocephalus; EPS, extrapyramidal syndromes; ALS, amyotrophic lateral sclerosis; VE, vascular encephalopathy; BP, Bell’s palsy.